Incidence and Demographics of Pediatric Intracranial Hypertension

Natalie Gillson1, Charlotte Jones2, Rachel E Reem3

  • 1Division of Pediatric Neurology, Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida.

Pediatric Neurology
|July 3, 2017
PubMed

Insights

The annual incidence of pediatric intracranial hypertension in central Ohio is 0.63 per 100,000 for primary (idiopathic) and 0.32 per 100,000 for secondary forms. These rates are comparable to international pediatric studies.

Area of Science:

  • Neurology
  • Pediatrics
  • Epidemiology

Background:

  • Pediatric intracranial hypertension (PIH) is a condition requiring accurate incidence data for public health and clinical management.
  • Understanding the demographic features of PIH is crucial for targeted interventions and resource allocation.

Purpose of the Study:

  • To determine the incidence and demographic characteristics of pediatric intracranial hypertension.
  • To compare pediatric incidence rates with adult populations and international pediatric data.

Main Methods:

  • Retrospective analysis of inpatient and outpatient encounters for children (≤18 years) diagnosed with intracranial hypertension from January 2010 to December 2013.
  • Data collected from a specialized PIH clinic and a children's hospital in a Midwestern US city.
  • Incidence rates calculated using patient diagnoses and census data for a seven-county service area, accounting for 92.3% of regional pediatric care.

Main Results:

  • A total of 74 pediatric patients were diagnosed with PIH (49 primary/idiopathic, 25 secondary) during the study period.
  • The calculated annual incidence rates were 0.63 per 100,000 children for primary PIH and 0.32 per 100,000 for secondary PIH.
  • Demographic data including sex, race, BMI, socioeconomic status, and geographic distribution were collected.

Conclusions:

  • The estimated annual incidence of pediatric primary intracranial hypertension in central Ohio is comparable to previous international pediatric reports.
  • The incidence of pediatric primary intracranial hypertension is approximately 67% of that reported in the US adult population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.5K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
423
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.1K